Xiamen Baysen Medical Tech Co., Ltd. is excited to introduce our latest product, the Creatine Kinase Isoenzyme MB test. This innovative test is designed to measure the levels of the MB isoform of creatine kinase, an important enzyme that is released into the bloodstream after a heart attack. With high sensitivity and specificity, this test can help diagnose myocardial infarction early and accurately, allowing for prompt medical intervention and improved patient outcomes.
As a leading manufacturer, supplier, and factory of medical diagnostic products in China, Xiamen Baysen Medical Tech Co., Ltd. is committed to providing high-quality, reliable, and affordable solutions to healthcare professionals worldwide. Our Creatine Kinase Isoenzyme MB test is CE and FDA approved, ensuring its safety and effectiveness. The test is easy to use, requiring only a small sample of blood and minimal equipment.
In conclusion, the Creatine Kinase Isoenzyme MB test from Xiamen Baysen Medical Tech Co., Ltd. offers a reliable and cost-effective solution for the diagnosis of myocardial infarction. Contact us today to learn more about this product and our other innovative medical diagnostic products.